From: Maternal ABVD chemotherapy for Hodgkin lymphoma in a dichorionic diamniotic pregnancy: a case report
Patient: 41 years old | Weight (kg): 85 Size (cm): 173 Body surface area (m2): 1,99 Creatinine (μmol/L): 58 Clearance(mL/min, Cockroft Gault): 151 | Unit: Hematology Cycle 1 J1 = November 08, 2017 Cycle duration: 28 days | |||||
---|---|---|---|---|---|---|---|
Drug | Dose of protocol | Total dose | Vehicle | Medical device | Route | Duration | Timing |
Doxorubicin | 25 mg/m2 | 50 mg | Glucose 5% 20 mL | Syringe | Intravenous | 5 min | J1 and J15 |
Bleomycin | 10 mg/m2 | 19.8 mg | Sodium chloride 0.9% 20 mL | Syringe | Intravenous | 5 min | J1 and J15 |
Vinblastine | 5 mg/m2 | 10 mg | Sodium chloride 0.9% 20 mL | Bag | Intravenous | 5 min | J1 and J15 |
Dacarbazine | 375 mg/m2 | 750 mg | Glucose 5% 250 mL | Bag | Infusion | 45 min | J1 and J15 |
Ondansetron | 8 mg | 8 mg | No dilution | Intravenous | 1 min | J1 and J15 | |
Dexamethasone | 10 mg | 10 mg | No dilution | Intravenous | 5 min | J1 and J15 |